Is Donanemab really a turning point for Alzheimer's treatment? | 7.30

Drug company Eli Lilly recently announced the trial results of an Alzheimer's disease medication. They claimed the drug Donanemab caused significant slowing of the dementia process in people with early memory problems. But not everyone is convinced. Norman Swan reports.
Subscribe: ab.co/3yqPOZ5
ABC News In-depth takes you deeper on the big stories, with long-form journalism from Four Corners, Foreign Correspondent, Australian Story, Planet America and more, and explainers from ABC News Video Lab.
Watch more ABC News content ad-free on ABC iview: ab.co/2OB7Mk1
For more from ABC News, click here: ab.co/2kxYCZY
Get breaking news and livestreams from our ABC News channel: / newsonabc
Like ABC News on Facebook: / abcnews.au
Follow ABC News on Instagram: / abcnews_au
Follow ABC News on Twitter: / abcnews
Note: In most cases, our captions are auto-generated.
#ABCNewsIndepth #ABCNewsAustralia

[@ritam6674]

A good and balanced report